About
Myolex is disrupting how to measure muscle wasting (and treatment), caused by obesity drugs, aging, and sport injuries. Myolex® EIM is a patented device technology and SaaS data analytics platform that is built to disrupt skeletal muscle measurement by becoming the clinical and wellness standard to aid in the diagnosis and treatment of obesity drug and age-related muscle wasting. Myolex has developed the 1st quantitative, sensitive, painless, portable for home use muscle quality assessment device that is specifically designed to non-invasively, comprehensibly, and precisely detect and monitor single muscle wasting.
Technologies
Cloudflare DNS
Gmail
Google Apps
CloudFlare Hosting
Google Font API
Varnish
Mobile Friendly
WordPress.org
Node.js
IoT
Android
Remote
AI
Keywords
medical equipment manufacturing
deep learning analysis
fat and connective tissue measurement
muscle wasting monitoring
muscle impedance spectral analysis
electrical impedance myography
muscle inflammation detection
medical devices
medical equipment and supplies manufacturing
reproducible muscle assessment
muscle biopsy alternative
muscle microarchitecture
disease progression tracking
disease-specific muscle assessment
faster clinical trials
als early diagnosis
glp-1 obesity drug muscle loss
healthcare technology
b2c
reduced trial size
als muscle deterioration
b2b
muscle atrophy detection
clinical research tool
portable muscle scanner
in-home muscle monitoring
quantitative muscle biomarker
non-invasive muscle diagnostics
bioimpedance technology
sarcopenia assessment
Company Information
-
Employees 9
-
Founded 2009
Location
1309 Beacon St, Brookline, Massachusetts, United States, 02446
